Official recall notice

FDA DrugClass IIINotable

Trokendi XR topiramate extended-release Recall (Jul 2026)

Product: Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.

Recall date
2026-07-29
Category
Drug
FDA class
Class III

Why it was recalled

Hazard

Failed Dissolution Specifications

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Failed Dissolution Specifications

Affected products

Lot # 2075801, Exp Date: 31-Oct-2029.

Verify with the official notice →
Share:

Related Recalls

2026-10-09 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Brevital Sodium 500 mg/vial for Injection
Par Pharmaceutical
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-09-30 · FDA_DRUG
FDA Recall: Reliable -1 Laboratories, Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, Sterile, 0.5 FL OZ
Sterling Pharmaceutical Services LLC